RADNOR, Pa., May 13, 2022 /PRNewswire/ — Following the launch of QUVIVIQ™ (daridorexant) CIV on May 2, Idorsia Pharmaceuticals, U.S. Inc. announced today that the first wave of patients has been prescribed the product through a pharmacy services provider. The pharmacy services provider…
News Ticker
- [ June 6, 2023 ] AHN, Cigna contract battle threatens to cut in-network coverage to up to 20K News
- [ June 6, 2023 ] Manager/Sr Mgr- Gross to Net & Government Pricing (Finance) – Kedrion Biopharma Inc. – Fort Lee, NJ Jobs
- [ June 6, 2023 ] Associate Director, Operations Portfolio Lead – Cell Therapy – Bristol Myers Squibb – Summit, NJ Jobs
- [ June 6, 2023 ] Associate Director, Operations Portfolio Lead – Cell Therapy – Bristol Myers Squibb – Princeton, NJ Jobs
- [ June 6, 2023 ] Merck sued the US to block the drug pricing law. Will other pharma companies follow suit? News
Copyright © 2023 Biotech Networks, LLC
Be the first to comment